| Laura Lynn Johnson, FNP | |
|
1619 Nw Hawthorne Ave Ste 204, Grants Pass, OR 97526 | |
| (541) 916-8530 | |
| (541) 916-8533 |
| Full Name | Laura Lynn Johnson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 15 Years |
| Location | 1619 Nw Hawthorne Ave Ste 204, Grants Pass, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023348430 | NPI | - | NPPES |
| 500616623 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 201050002NP (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Accentcare Home Health Of Rogue Valley, Llc | Medford, OR | Home health agency |
| Providence Medford Home Care | Medford, OR | Home health agency |
| Signature Healthcare At Home | Central point, OR | Home health agency |
| Asante Rogue Regional Medical Center | Medford, OR | Hospital |
| Asante Three Rivers Medical Center | Grants pass, OR | Hospital |
| Providence Medford Medical Center | Medford, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Laura L. Johnson, N.p., P.c. | 8729340187 | 3 |
News Archive
A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today.
USAID's "IMPACTblog" interviews Regina Ombam, head of strategy for the Kenya National AIDS Control Council (NACC), and Irene Mukui, the antiretroviral therapy (ART) program manager for Kenya's National AIDS and STI Control Program, regarding a Cabinet memorandum prepared by the NACC in March that outlines ways to raise funds for HIV programming.
A parasitic worm may hold the answer to keeping skin grafts firmly in place over wounds, according to a new study by researchers at Brigham and Women's Hospital (BWH).
Prostate cancer, the second leading cause of cancer death for men in the United States, is caused by changes in several tummor suppressor genes including PTEN and p53. Up to 70 percent of men with prostate cancer have lost one copy of the PTEN gene at the time of diagnosis, and p53 is absent in a high number of patients with advanced prostate cancer.
› Verified 4 days ago
| Entity Name | Kathleen S Finley |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609850940 PECOS PAC ID: 6305839283 Enrollment ID: O20040406001311 |
News Archive
A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today.
USAID's "IMPACTblog" interviews Regina Ombam, head of strategy for the Kenya National AIDS Control Council (NACC), and Irene Mukui, the antiretroviral therapy (ART) program manager for Kenya's National AIDS and STI Control Program, regarding a Cabinet memorandum prepared by the NACC in March that outlines ways to raise funds for HIV programming.
A parasitic worm may hold the answer to keeping skin grafts firmly in place over wounds, according to a new study by researchers at Brigham and Women's Hospital (BWH).
Prostate cancer, the second leading cause of cancer death for men in the United States, is caused by changes in several tummor suppressor genes including PTEN and p53. Up to 70 percent of men with prostate cancer have lost one copy of the PTEN gene at the time of diagnosis, and p53 is absent in a high number of patients with advanced prostate cancer.
› Verified 4 days ago
| Entity Name | Laura L. Johnson, N.p., P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447752035 PECOS PAC ID: 8729340187 Enrollment ID: O20180322001584 |
News Archive
A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today.
USAID's "IMPACTblog" interviews Regina Ombam, head of strategy for the Kenya National AIDS Control Council (NACC), and Irene Mukui, the antiretroviral therapy (ART) program manager for Kenya's National AIDS and STI Control Program, regarding a Cabinet memorandum prepared by the NACC in March that outlines ways to raise funds for HIV programming.
A parasitic worm may hold the answer to keeping skin grafts firmly in place over wounds, according to a new study by researchers at Brigham and Women's Hospital (BWH).
Prostate cancer, the second leading cause of cancer death for men in the United States, is caused by changes in several tummor suppressor genes including PTEN and p53. Up to 70 percent of men with prostate cancer have lost one copy of the PTEN gene at the time of diagnosis, and p53 is absent in a high number of patients with advanced prostate cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Lynn Johnson, FNP Po Box 550, Eagle Point, OR 97524-0550 Ph: (541) 830-0333 | Laura Lynn Johnson, FNP 1619 Nw Hawthorne Ave Ste 204, Grants Pass, OR 97526 Ph: (541) 916-8530 |
News Archive
A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today.
USAID's "IMPACTblog" interviews Regina Ombam, head of strategy for the Kenya National AIDS Control Council (NACC), and Irene Mukui, the antiretroviral therapy (ART) program manager for Kenya's National AIDS and STI Control Program, regarding a Cabinet memorandum prepared by the NACC in March that outlines ways to raise funds for HIV programming.
A parasitic worm may hold the answer to keeping skin grafts firmly in place over wounds, according to a new study by researchers at Brigham and Women's Hospital (BWH).
Prostate cancer, the second leading cause of cancer death for men in the United States, is caused by changes in several tummor suppressor genes including PTEN and p53. Up to 70 percent of men with prostate cancer have lost one copy of the PTEN gene at the time of diagnosis, and p53 is absent in a high number of patients with advanced prostate cancer.
› Verified 4 days ago
Ms. Catherine Chiaradonna, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1867 Williams Hwy Ste 226, Grants Pass, OR 97527 Phone: 877-672-8620 | |
Cathryn Diann Draper, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 520 Sw Ramsey Ave Ste 204, Grants Pass, OR 97527 Phone: 541-930-7223 Fax: 541-930-7221 | |
Deborah Lynn Rossel, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1600 Nw 6th St, Grants Pass, OR 97526 Phone: 541-916-5500 Fax: 541-916-5010 | |
Krista Fuqua, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1585 Nw Washington Blvd, Grants Pass, OR 97526 Phone: 541-474-5511 | |
Mona Kaahu, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1701 Nw Hawthorne Ave, Grants Pass, OR 97526 Phone: 541-471-3455 Fax: 541-471-9242 | |
Ms. Charlane A Frazier, WHCNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 160 Nw Franklin Blvd, Grants Pass, OR 97526 Phone: 541-474-2784 Fax: 541-474-0638 |